regulatory | CARA Life Sciences

pharma& chooses CARA Life Sciences Platform as basis for its Regulatory, Quality and Legal System

Generis, creator of the cloud data, content, and business process management platform CARA, announces that pharma& has selected the CARA™...

Theramex select CARA Life Sciences Platform to consolidate and digitise Regulatory Processes

London, UK – 2nd February 2023 - Generis, creator of the cloud data, content, and business process management platform CARA, today...

The Big Debate - The Future Will be Data Driven

In December 2022, thought leaders from BioNTech, Bayer, Iperion a Deloitte Company, and Beczek Consulting joined Generis for a live video...

German Pharma Company selects Generis’ CARA Life Sciences Platform to Unify Their Clinical Processes

London, UK – 18th January 2023 – Generis, provider of the CARA Life Sciences Platform for managing the business processes, data, and...

Global Pharma Company Merz Choose Generis’ CARA Life Sciences Platform to Consolidate R&D Process

London, UK - 14th December 2022 - Generis, creator of the cloud data, content, and business process management platform CARA, announced...

Transforming Regulatory Affairs

Find out how the CARA Life Sciences Platform enables companies to simplify, standardise and automate regulatory processes

Buckle up – 2022 is going to be a heck of a year for regulatory process reinvention in Life Sciences

It’s with a great sense of promise and excitement that I have begun my new role with Generis as Head of Life Sciences. It’s very clear...

Generis appoints Head of Life Sciences as CARA™ growth soars

We're delighted to welcome Mark Willoughby as our new Head of Life Sciences.

Medical device manufacturers need their own regulatory, quality & safety management platform

Medical device manufacturers have long been the neglected cousins of pharma companies in terms of IT systems that specifically cater to...

Medical device & pharma manufacture are not the same

Digital transformation goals and software support needs are likely to differ If there’s one thing medical device manufacturers want...